A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer
Clinical trial NCT00089479 · COMPLETED
Trial details
- NCT number
- NCT00089479
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2010-06-01
- Enrollment
- 2611
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.